About Studybox

Born from Toolbox Medical Innovations, Studybox Research is a full‑service IVD CRO with 30+ years of experience and 50+ FDA clearances.

We simplify diagnostic trials by combining CRO services with our dedicated site network, cutting down complexity and delivering reliable results faster.

Join us

Who We Are

We are a team of innovators and problem-solvers united by a shared passion for advancing in vitro diagnostics and transforming the future of patient care.

Jenn Zeis

Founder & CEO

Colleen Monaco

CCRO

Meghan Alonso

CCO

Chris daCosta

COO

Our Board of Directors

John Zeis
Strategic Advisor
Elliot Cowan, PhD
Regulatory Advisor
Dan Hughes
Strategic Advisor
Ronald Salzetti, MD
Womens Health Advisor
Frank Calcagno, MD
Pediatric Advisor
Support

Frequently Asked
Questions

What makes Studybox different from other CROs or SMOs?
Studybox focuses exclusively on in-vitro diagnostics (IVDs). Unlike traditional CROs or SMOs, we combine CRO expertise with a dedicated network of IVD sites, streamlining studies and accelerating regulatory approval.
What is the process for Starting a study with Studybox?
Simply reach out to our team with your study goals. We’ll guide you through site selection, protocol design, regulatory strategy, and study launch ensuring a seamless experience from start to finish.
Do Studybox sites reflect real-world clinical environments?
Yes. Our geographically diverse network includes Point of Care (POC), urgent care, and home-use settings, ensuring your study captures data that reflects real-world IVD use.
Can Studybox support regulatory submissions?
Absolutely. With IVD operations and regulatory expertise, we simplify and accelerate your clinical research. Our team supports study planning, electronic study management, data analysis, regulatory submission, and agency communication, all backed by an ISO 9001:2015 and 20916:2019 compliant quality system.
What type of studies does Studybox specialize in?
We focus on reproducibility, specimen collection, near cut-off, and intended-use studies for IVDs, ensuring reliable results that meet FDA expectations.